2-(1-(3-chlorophenyl)-2-hydroxyethyl)-6-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)isoindolin-1-one

ID: ALA4567212

PubChem CID: 146634737

Max Phase: Preclinical

Molecular Formula: C24H21ClN6O2

Molecular Weight: 460.93

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cn1nccc1Nc1nccc(-c2ccc3c(c2)C(=O)N(C(CO)c2cccc(Cl)c2)C3)n1

Standard InChI:  InChI=1S/C24H21ClN6O2/c1-30-22(8-10-27-30)29-24-26-9-7-20(28-24)15-5-6-17-13-31(23(33)19(17)12-15)21(14-32)16-3-2-4-18(25)11-16/h2-12,21,32H,13-14H2,1H3,(H,26,28,29)

Standard InChI Key:  SCFLWNGBEZTNIR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
    3.8080   -7.4537    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8069   -8.2733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5149   -8.6822    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2246   -8.2728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2217   -7.4501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5131   -7.0449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9294   -8.6795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9294   -9.4978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6369   -9.9052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6329   -8.2704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0988   -8.6813    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3410   -8.6741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3480   -9.4926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1286   -9.7389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6041   -9.0726    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1173   -8.4145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3632   -7.6352    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4213   -9.0655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8359   -9.7697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8238   -8.3543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6412   -8.3511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0437   -7.6407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6289   -6.9356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8076   -6.9452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4088   -7.6561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6531   -9.7627    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0982   -9.4985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8608   -7.6341    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.4366   -9.9807    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6886  -10.7581    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5058  -10.7588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7588   -9.9817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6594   -9.7285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 13  2  0
 12 10  2  0
 10  7  1  0
  4  7  1  0
  2 11  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 12  1  0
 16 17  2  0
 15 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 19 26  1  0
 11 27  1  0
 22 28  1  0
 27 29  1  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 27  2  0
 29 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4567212

    ---

Associated Targets(Human)

SW626 (166 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
WM 266-4 (208 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK3 Tchem MAP kinase ERK1 (4725 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK1 Tchem MAP kinase ERK2 (25055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
COLO 205 (50209 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 460.93Molecular Weight (Monoisotopic): 460.1415AlogP: 3.96#Rotatable Bonds: 6
Polar Surface Area: 96.17Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.21CX Basic pKa: 3.06CX LogP: 3.47CX LogD: 3.47
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.45Np Likeness Score: -1.24

References

1. Ji D, Zhang L, Zhu Q, Bai Y, Wu Y, Xu Y..  (2019)  Discovery of potent, orally bioavailable ERK1/2 inhibitors with isoindolin-1-one structure by structure-based drug design.,  164  [PMID:30605831] [10.1016/j.ejmech.2018.12.040]

Source